Latest Schedule 13G passive stakes

Laurence W. Lytton has reported beneficial ownership of 5,592,972 shares, representing 5.2% of Codexis, Inc. common stock, as of June 30, 2026.

Laurence W. Lytton and the Lytton-Kambara Foundation have jointly filed a Schedule 13G, reporting a combined beneficial ownership of approximately 9.9% in Scientific Industries Inc., indicating a substantial passive investment.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.7% of Esperion Therapeutics, Inc. common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 6.7% of Esperion Therapeutics, Inc. common stock as of June 30, 2026.

Laurence W. Lytton has reported a beneficial ownership of 9.6% in MDxHealth SA's ordinary shares.

Invesco Ltd. has disclosed a beneficial ownership of 13,678,393 shares, representing 7.3% of the common stock of Allegro MicroSystems Inc.

Invesco Ltd. has disclosed a beneficial ownership of 13,678,393 shares, representing 7.3% of the common stock of Allegro MicroSystems Inc.

Brandes Investment Partners, L.P. has updated its Schedule 13G filing to reflect its beneficial ownership of Globant S.A. common shares.

Laurence W. Lytton has filed a Schedule 13G, reporting beneficial ownership of 959,856 shares, representing 7.5% of Ideal Power Inc.'s common stock.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Chart Industries, Inc. common stock.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Chart Industries, Inc. common stock.

Enstar Group Limited and affiliated entities report a 5.6% beneficial ownership stake in James River Group Holdings, Ltd. common shares.

Enstar Group Limited and affiliated entities report a 5.6% beneficial ownership stake in James River Group Holdings, Ltd. common shares.

Enstar Group Limited and its affiliates have disclosed a significant beneficial ownership stake of 16.6% in Eagle Point Income Company, Inc.

Enstar Group Limited and its affiliates have disclosed a significant beneficial ownership stake of 16.6% in Eagle Point Income Company, Inc.

Invesco Ltd. has disclosed beneficial ownership of 10,365,640 shares, representing 5.0% of the common stock of Alignment Healthcare Inc., as of June 30, 2026.

Invesco Ltd. has disclosed beneficial ownership of 10,365,640 shares, representing 5.0% of the common stock of Alignment Healthcare Inc., as of June 30, 2026.

Laurence W. Lytton has reported beneficial ownership of 4,238,628 shares, representing 4.9% of Rein Therapeutics, Inc. common stock, as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.5% of Bold Eagle Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.5% of Bold Eagle Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

Laurence W. Lytton has filed a Schedule 13G, reporting beneficial ownership of 9.99% of Guerrilla RF, Inc.'s common stock, including shares and warrants.

LaSalle Investment Management Securities LLC has reported beneficial ownership of 7.6% of National Healthcare Properties, Inc. common stock.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amendment to their Schedule 13G, reporting their beneficial ownership of Boston Beer Co Inc Class A Common Stock.

Ashford Capital Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 4.9% of Vox Royalty Corp.'s common shares as of June 30, 2026.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amendment to their Schedule 13G, reporting beneficial ownership of 6.93% of SentinelOne, Inc.'s Class A common stock as of June 30, 2026.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have amended their Schedule 13G filing to report beneficial ownership of 5.59% of Selective Insurance Group Inc.'s common stock.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have disclosed beneficial ownership of over 5% of Sarepta Therapeutics, Inc. common stock, acquiring 5,329,691 shares.

Ashford Capital Management, Inc. has amended its Schedule 13G filing to report beneficial ownership of 4.2% of ReposiTrak, Inc.'s common shares as of June 30, 2026.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed a Schedule 13G, reporting beneficial ownership of 5.02% of Repay Holdings Corp's Class A Common Stock.

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed an amendment to their Schedule 13G, reporting a beneficial ownership of 6.83% in Molina Healthcare, Inc.